Health Catalyst
HCAT
167 hedge funds and large institutions have $376M invested in Health Catalyst in 2024 Q4 according to their latest regulatory filings, with 30 funds opening new positions, 61 increasing their positions, 48 reducing their positions, and 20 closing their positions.
18,317% more call options, than puts
Call options by funds: $21M | Put options by funds: $114K
50% more first-time investments, than exits
New positions opened: 30 | Existing positions closed: 20
27% more repeat investments, than reductions
Existing positions increased: 61 | Existing positions reduced: 48
5% more funds holding
Funds holding: 159 → 167 (+8)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
0.9% less ownership
Funds ownership: 86.05% → 85.14% (-0.9%)
11% less capital invested
Capital invested by funds: $423M → $376M (-$47.5M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FLAM
First Light Asset Management
Edina,
Minnesota
|
+$7.52M |
| 2 |
Alyeska Investment Group
Chicago,
Illinois
|
+$6.86M |
| 3 |
KCM
Kennedy Capital Management
St Louis,
Missouri
|
+$4.5M |
| 4 |
PCM
Penn Capital Management
Philadelphia,
Pennsylvania
|
+$3.95M |
| 5 |
PVM
Palogic Value Management
Dallas,
Texas
|
+$2.55M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NI
Nepsis Inc
Minneapolis,
Minnesota
|
-$16M |
| 2 |
Bank of New York Mellon
New York
|
-$6.89M |
| 3 |
GIM
Granahan Investment Management
Waltham,
Massachusetts
|
-$4.29M |
| 4 |
Primecap Management
Pasadena,
California
|
-$3.76M |
| 5 |
FAM
Fred Alger Management
New York
|
-$3.74M |
HCAT Hedge Fund Activity: Q4 2024 in Review
167 of the 7,606 institutional investors tracked by Wall St. Rank reported a position in Health Catalyst (HCAT) for Q4 2024, worth a combined $376M — down 11% from $423M a quarter earlier.
Buyers outnumbered sellers: 30 funds opened new HCAT positions and 20 closed out — a net gain of 10 holders — while 61 added to existing stakes and 48 trimmed.
The largest buyer was First Light Asset Management, adding an estimated $7.52M. The largest seller was Nepsis Inc, cutting an estimated $16M.
- 167 institutional investors held Health Catalyst (HCAT) as of Q4 2024, up from 159 in Q3 2024.
- Funds reported $376M of Health Catalyst stock for Q4 2024, down 11% quarter-over-quarter.
- 30 funds opened new Health Catalyst positions in Q4 2024 and 20 closed out, a net change of +10 holders.
- The largest Health Catalyst buyer in Q4 2024 was First Light Asset Management, an estimated $7.52M added.
- The largest Health Catalyst seller in Q4 2024 was Nepsis Inc, an estimated $16M sold.
Based on aggregated 13F filings for Q4 2024.